Genetron Holdings (Genetron Holdings) EPS (Basic) : $-3.52 (TTM As of Jun. 2022)

View and export this data going back to 2020. Start your Free Trial

What is Genetron Holdings EPS (Basic)?

Genetron Holdings's basic earnings per share (Basic EPS) for the three months ended in Jun. 2022 was $-1.14. Its basic earnings per share (Basic EPS) for the trailing twelve months (TTM) ended in Jun. 2022 was $-3.52.

Genetron Holdings's EPS (Diluted) for the three months ended in Jun. 2022 was $-1.14. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Jun. 2022 was $-3.52.

Genetron Holdings's EPS without NRI for the three months ended in Jun. 2022 was $-1.10. Its EPS without NRIearnings per share without non-recurring items for the trailing twelve months (TTM) ended in Jun. 2022 was -3.30.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

Genetron Holdings EPS (Basic) Historical Data

The historical data trend for Genetron Holdings's EPS (Basic) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Genetron Holdings EPS (Basic) Chart

Genetron Holdings Annual Data

Trend

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

EPS (Basic)

Get a 7-Day Free Trial

-2.93

-4.19

-23.35

-2.54

-3.74

Genetron Holdings Quarterly Data
	Dec17	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Dec22
EPS (Basic)	Get a 7-Day Free Trial													-0.65	-0.82	-0.90	-1.14	-

Genetron Holdings EPS (Basic) Calculation

EPS (Basic) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Basic earnings per share (EPS) do not factor in the dilutive effects on convertible securities.

Genetron Holdings's Basic EPS for the fiscal year that ended in Dec. 2022 is calculated as

Basic EPS (A: Dec. 2022 )	=	(Net Income	-	Preferred Dividends)	/	Shares Outstanding (Basic Average)
	=	(-115.955	-	0)	/	30.932
	=	-3.75

Genetron Holdings's Basic EPS for the quarter that ended in Jun. 2022 is calculated as

Basic EPS (Q: Jun. 2022 )	=	(Net Income	-	Preferred Dividends)	/	Shares Outstanding (Basic Average)
	=	(-35.132	-	0)	/	30.906
	=	-1.14

EPS (Basic) for the trailing twelve months (TTM) ended in Jun. 2022 adds up the quarterly data reported by the company within the most recent 12 months, which was $-3.52

Genetron Holdings (NAS:GTH) EPS (Basic) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.

Genetron Holdings EPS (Basic) Related Terms

Thank you for viewing the detailed overview of Genetron Holdings's EPS (Basic) provided by GuruFocus.com. Please click on the following links to see related term pages.

Genetron Holdings (Genetron Holdings) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Genetron Holdings Ltd (NAS:GTH) » Definitions » EPS (Basic)

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 8 Life Science Parkway, 1-2nd Floor, Building 11, Zone 1, Changping District, Beijing, CHN, 102206

Website

https://www.genetronhealth.com

Genetron Holdings Ltd is an oncology company in China. It is specialized in cancer molecular profiling and harnesses advanced technologies in molecular biology and data science to transform cancer treatment. The company's operating segment includes Diagnosis and monitoring - provision for LDT services; Diagnosis and monitoring - sale of IVD products and Development services. It generates maximum revenue from the Diagnosis and monitoring - provision for LDT services segment.